Staff at pharmaceutical company
WE CARE

BROAD SPECTRUM

Our portfolio covers the entire value chain in the pharma and biopharma industries
published over a month ago
Photo: Bilfinger

F

rom project management and engineering through to the assembly, maintenance and modernization of plants as well as their shutdown – thanks to its many years of expertise Bilfinger is in a position to meet all the requirements of its customers in the pharma and biopharma industries. Services include technologies for sterile, clean and ultra-clean rooms. This is on top of apparatus engineering and the laying of piping systems. The range of services also includes installation of electrical instrumentation, measurement and control technology as well as solutions for the automation and digitalization of plants.

BUNDLED EXPERTISE

 

With this series, we present our service portfolio in our core industries.

One of Bilfinger’s specializations in the area of pharma and biopharma is the construction of large and complex biotech process units also known as skids or super skids. These modules are fully assembled by Bilfinger at the production location and subjected to the required factory acceptance testing. This simplifies and accelerates their installation in the customer’s plant. The welding and testing technologies that are applied in the production of the skids are state-of-the-art. In connection with modern manufacturing management and digitalized logistics, they ensure the highest possible level of production quality.

 

A significant portion of the value chain is represented by tasks associated with the maintenance and repair of plant components. With the modular Bilfinger Maintenance Concept, customers in the pharma and biopharma industries have access to a proven solution that allows them to reduce operating costs over the long term.


A

bioreactor, often also referred to as a fermenter, is a container in which micro-organisms are cultivated in conditions that are as near to perfect as possible. It serves to cultivate cells or metabolic products. In the reactor, factors such as the composition of the nutrient medium, the supply of oxygen, the temperature or the pH level can be managed or controlled.

 

The first bioreactors were manufactured at Bilfinger Industrietechnik Salzburg already in the 1980s. Since then, the company has gained comprehensive experience in the design and manufacture of these systems. On the basis of this expertise, an in-house, modularly-designed range of bioreactors was developed. The spectrum ranges from devices for laboratory application with container volume of 15 liters through to large devices with a volume of 4,000 liters. Bilfinger also manufactures customer- specific individual solutions for fermenting plants with a volume of up to 40,000 liters.

Home
Browse archive
View all